Literature DB >> 2894360

Effects of adenylate cyclase toxin from Bordetella pertussis on human neutrophil interactions with Coccidioides immitis and Staphylococcus aureus.

J N Galgiani1, E L Hewlett, R L Friedman.   

Abstract

Bordetella pertussis extract that contained adenylate cyclase toxin produced large increases in human neutrophil cyclic AMP levels and inhibited their oxidative burst, as reflected by luminol-enhanced chemiluminescence and superoxide release. The adenylate cyclase toxin-containing extract blocked neutrophil-mediated inhibition of N-acetylglucosamine incorporation by arthroconidia of Coccidioides immitis in a dose-dependent fashion but had no effect on neutrophil phagocytosis of Candida glabrata and only a slight inhibitory effect on arthroconidial attachment. Neither purified pertussis toxin nor extracts from Bordetella mutants lacking the adenylate cyclase toxin affected neutrophil-mediated inhibition of arthroconidial N-acetylglucosamine incorporation. These studies indicate that adenylate cyclase toxin, alone or in concert with other B. pertussis-elaborated toxins, blocks neutrophil inhibition of arthroconidia, primarily by affecting neutrophil responses other than attachment or phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894360      PMCID: PMC259365          DOI: 10.1128/iai.56.4.751-755.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  A study of stimuli leading to the production of spherules in coccidioidomycosis.

Authors:  O BAKER; A I BRAUDE
Journal:  J Lab Clin Med       Date:  1956-02

2.  Gammaflow: a completely automated radioimmunoassay system.

Authors:  G Brooker; W L Terasaki; M G Price
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

3.  A cytological study of morphogenesis in Coccidioides immitis.

Authors:  S H Sun; M Huppert
Journal:  Sabouraudia       Date:  1976-07

4.  Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion.

Authors:  T Katada; M Ui
Journal:  J Biol Chem       Date:  1980-10-25       Impact factor: 5.157

5.  Phagocytosis measured as inhibition of uridine uptake by Candida albicans.

Authors:  M Yamamura; J Boler; H Valdimarsson
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

6.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

7.  Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro.

Authors:  R D Diamond; R Krzesicki; W Jao
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

8.  Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

9.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

10.  Biological defense mechanisms. The effect of bacteria and serum on superoxide production by granulocytes.

Authors:  J T Curnutte; B M Babior
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

View more
  3 in total

1.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Bordetella pertussis induces respiratory burst activity in human polymorphonuclear leukocytes.

Authors:  L L Steed; E T Akporiaye; R L Friedman
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 3.  Virulence factors of Bordetella pertussis.

Authors:  F R Mooi
Journal:  Antonie Van Leeuwenhoek       Date:  1988       Impact factor: 2.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.